Abstract

Vasodilators are an important class of antihypertensive agents. However, they have limited clinical use due to the reflex tachycardia associated with their use which masks most of its antihypertensive effect and raises cardiac risk. Chemical investigation of Psiadia punctulata afforded five major methoxylated flavonoids (1–5) three of which (1, 4, and 5) showed vasodilator activity. Linoleic acid-based self-nanoemulsifying drug delivery system (SNEDDS) was utilized to develop intravenous (IV) formulations that contain compounds 1, 4, or 5. The antihypertensive effect of the prepared SNEDDS formulations, loaded with each of the vasodilator compounds, was tested in the angiotensin-induced rat model of hypertension. Rats were subjected to real-time recording of blood hemodynamics and surface Electrocardiogram (ECG) while the pharmaceutical formulations were individually slowly injected in cumulative doses. Among the tested formulations, only that contains umuhengerin (1) and 5,3′-dihydroxy-6,7,4′,5′-tetramethoxyflavone (5) showed potent antihypertensive effects. Low IV doses, from the prepared SNEDDS, containing either compound 1 or 5 showed a marked reduction in the elevated systolic blood pressure by 10 mmHg at 12 μg/kg and by more than 20 mmHg at 36 μg/kg. The developed SNEDDS formulation containing either compound 1 or 5 significantly reduced the elevated diastolic, pulse pressure, dicrotic notch pressure, and the systolic–dicrotic notch pressure difference. Moreover, both formulations decreased the ejection duration and increased the non-ejection duration while they did not affect the time to peak. Both formulations did not affect the AV conduction as appear from the lack of effect on p duration and PR intervals. Similarly, they did not affect the ventricular repolarization as no effect on QTc or JT interval. Both formulations decreased the R wave amplitude but increased the T wave amplitude. In conclusion, the careful selection of linoleic acid for the development of SNEDDS formulation rescues the vasodilating effect of P. punctulata compounds from being masked by the reflex tachycardia that is commonly associated with the decrease in peripheral resistance by most vasodilators. The prepared SNEDDS formulation could be suggested as an effective medication in the treatment of hypertensive emergencies, after clinical evaluation.

Highlights

  • Hypertension is one of the most common chronic medical problems affecting more than one billion people all over the world (Chockalingam et al, 2006)

  • The present study aimed to evaluate the antihypertensive activity for the isolated methoxylated flavonoids from P. punctulata after administration of an IV formulation based on self-nanoemulsifying drug delivery system (SNEDDS) containing linoleic acid to unmask the effect of reflex tachycardia

  • ® Polyethylene glycol (PEG) 400, oleic acid, and Tween 80 were purchased from Sigma–Aldrich

Read more

Summary

INTRODUCTION

Hypertension is one of the most common chronic medical problems affecting more than one billion people all over the world (Chockalingam et al, 2006). Vasodilators form the mainstay of treatment in hypertensive emergencies (Mallidi et al, 2015) and a valuable agent in the treatment of systemic hypertension (Hariri and Patel, 2021) They have a limited clinical role due to the reflex tachycardia associated with their use, as a consequence of the medication-induced baroreflex response compensating for the sudden medication decrease in vascular resistance (Kester et al, 2012; Rascher and Paech, 2020), reflex tachycardia might propagate aortic dissection (Estrera et al, 2006). The present study aimed to evaluate the antihypertensive activity for the isolated methoxylated flavonoids from P. punctulata after administration of an IV formulation based on SNEDDS containing linoleic acid to unmask the effect of reflex tachycardia

MATERIALS AND METHODS
RESULTS AND DISCUSSION
ETHICS STATEMENT
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call